Report Overview
The market for infection control is anticipated to grow at a 4.6% CAGR from 2023 to 2030.
Bacteria, viruses, and fungi are the main microorganisms responsible for infection. There are many different types of infections, including Hospital Acquired Infections (HAIs), stomach and intestinal infections, eye, ear, lung, and respiratory infections, skin infections, and sexually transmitted infections brought on by the cross-contamination of patient and healthcare staff equipment, surfaces, and skin. To stop infectious diseases, infection control and prevention are practised. The most common HAIs include catheter-associated UTIs, bloodstream infections, and ventilator-associated pneumonia.
For More Insights request free Sample: https://www.datamintelligence.com/download-sample/infection-control-market
Market Dynamics
Some of the key factors propelling the market's growth in the anticipated period include the high incidence of HAIs, rising surgical procedures, an ageing population, an increase in chronic diseases like cancer, diabetes, obesity, heart disease, and respiratory disorders, as well as an increasing demand for food sterilisation and disinfection.
The market is anticipated to rise as hospital-acquired infections become more common.
Hospital-acquired infections (HAIs) are illnesses that develop 48 hours or more after admission or within 30 days of release and were contracted in a hospital or other healthcare facility, according to the World Health Organisation Report 2022. The pathogens that result in hospital-acquired infections include bacteria, fungi, and viruses. The most frequent infections are surgical site infections, urinary tract infections, pneumonia, and bloodstream infections (BSI).
These infections lengthen hospital stays, risk the patient's health and life, and increase the cost of care. Between 7% and 10% of all reported infections in both industrialised and developing countries are caused by these infections. At least one healthcare-associated infection (HAI) will be contracted by 7 patients in high-income nations and 15 patients in low- and middle-income countries during their stay in acute-care hospitals. Due to their HAI, one in ten impacted patients would pass away.
HAIs and antimicrobial resistance also have a significant influence on people's lives. More than 24% of individuals with healthcare-associated sepsis and 52.3% of those receiving critical care unit treatment pass away each year. In order to guarantee the effectiveness of care and the security of both patients and medical personnel, the WHO introduced IPC programmes. It has been demonstrated that increasing investment in IPC improves health outcomes and lowers healthcare costs and out-of-pocket spending, thus this will not only safeguard their communities. As a result of the aforementioned factors, the market is anticipated to lead throughout the forecast period.
Infection surveillance challenges are predicted to impede market expansion.
Many hospitals still use manual infection surveillance methods, such as patient isolation or infection preventionists looking for possible HAIs in paper culture results. These reports are typically delayed, which makes it harder to deal with HAI cases. Manual surveillance is time-consuming and has not been as successful at collecting information that may be used to develop and implement efficient preventive measures to reduce the incidence of drug-resistant infections. Infection control specialists find it challenging to make complex decisions. The impact of ignoring a device-related infection is less severe than the impact of overreporting an infectious event. Additionally, staff members at nearby facilities are hesitant to investigate instances that are not HAI, whereas those that are diagnosed as infections may also be examined, taking more time. As a result of the aforementioned factors, the market is anticipated to face difficulties over the projected period.
View Full Report: https://www.datamintelligence.com/research-report/infection-control-market
Infection Control Market Companies
Key players are Getinge AB, STERIS plc, Advanced Sterilization Products, 3M Company, Belimed AG, Cantel Medical Corporation, MMM Group, Matachana Group, Sotera Health LLC, and Metrex Research Corporation.
Related Reports:
Durable Medical Equipment Market
Media Contact
Company Name: DataM Intelligence
Email: [email protected]
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
Sign in to leave a comment.